Clinical Trial Update: A Phase II Study of Pioglitazone for Patients With Cancer of the Pancreas [Phase 2]

View source ↗

Summary

Phase II study investigating pioglitazone for cancer of the pancreas has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Cancer of the Pancreas | Phase 2 | Status: COMPLETED | Results posted: 2021-03-01